Source: HIT Consultant Media

Tandem: Tandem Diabetes Care Launches t:slim X2 Pump Integration with Abbott FreeStyle Libre 3 Plus Sensor

What You Should Know: - Tandem Diabetes Care, Inc. today announced that its t:slim X2 insulin pump, featuring the advanced Control-IQ+ automated insulin delivery (AID) technology, is now available with the integration of Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor in the United States. - The launch represents the first step in ... Read More

Read full article »

Tandem's Competitors | Tandem's News | Tandem's Financials

Followers on Owler

181

Annual Revenue

$1.0-5.0B

Employees

1.0-5.0K

President & CEO

John Sheridan

CEO Approval Rating

57/100

Tandem is a California-based medical device firm that manufactures and supplies products such as software-integrated insulin pumps and accessories for the healthcare sector.